Technically Speaking, page-1735

First 1735 Last

Share
Profile

Follow
Jardani

1,390 Posts.

116

20/02/20

14:31

Post #: 43048193
Share

Originally posted by Fela: ↑

IMO - If you are holding PO3 and have anything less than a 12 month period in mind you might be more than a little frustrated.

Such a tight register also means you are likely to suffer from whiplash as the SP lurches around. Geez...due to a kenikool spike yesterday we experienced a 16% jump then closed 4% down.

Significant rerating can occur very quickly - take the 5 sessions from 20/8/19 to 28/8/19 - an increase of 65% on the back of no particularly significant news. Similarly - the five sessions from 16/10 to 24/10 saw an increase of close to 40%.

Buying PO3 at $5 would certainly seem like a premium today. But $5 could look quite different in 12 months time. Or in 12 weeks time.

Finally - while I agree with the observation that the problem lies in lack of communication - I wouldn't have much basis to blame management poor execution (outside of the TB trial which was a communications disaster) - as we have little insight into what they have been up to - nor do we know of the extent of progress with OEMs. But I would very much doubt that the new BOD, Somnio and PO3 are playing corridor cricket.

We have a blue chip Chairman with blue chip contacts and credentials - located in Michigan - home of blue chip companies such as Whirlpool as mentioned above. There surely has to be some comfort in that!

(Pertinent quote stolen from Twitter) - "If you focus on long-term outcomes, expect to be misunderstood in the short term, frequently"

Expand

can you name 1 company that is in air purifiers that has market cap over 10 mil
this is 90 mil cap

so with no product talk of highs is a dream

PO3 Price at posting: $2.50 Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

First 1735 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Technically Speaking, page-1735

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News